"These novel findings suggest that targeted interventions for improving HDL, blood pressure, obesity, and dyslipidemia could mitigate MASLD risk." — Wu et al., Nutrition, 2024 Investigators conducted ...
Machine learning models have potential for early identification of patients with metabolic dysfunction-associated steatotic liver disease (MASLD) who are at risk of hepatocellular carcinoma. Machine ...
The 2024 European clinical practice guidelines introduce a pivotal terminology shift, replacing NAFLD (non-alcoholic fatty liver disease) with MASLD (metabolic dysfunction-associated steatotic liver ...
The authors provide a useful integrated analytical approach to investigating MASLD focused on diverse multiomic integration methods. The strength of evidence for this new resource is solid, as ...
Credit must be given to the creator. Only noncommercial uses of the work are permitted. Algorithm for non-invasive risk stratification of individuals with suspected MASLD (reproduced with ...
In a nationwide cohort study of Swedes with inflammatory bowel disease (IBD), histologic inflammation and clinically active disease were each associated with higher all-cause mortality at 2 years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback